Amyris

About

Amyris Biotechnologies specializes in creating renewable products focusing on fuels and chemicals.

Emeryville,California,United States
501 - 1000
http://amyris.com/

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $50M
Industries: Biotechnology,Chemical,CleanTech,Renewable Energy
Founded date: Jan 1, 2003
Number Of Employee: 501 - 1000
Operating Status: Active
Stock Symbol: nasdaq:AMRS
Legal Name: Amyris, Inc.
Also Known As: Amyris Biotechnologies

Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

27

$1.95B

Amyris has raised a total of $1.95B in funding over 2 rounds. Their latest funding was raised on Dec 29, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 29, 2022	Post-IPO Equity	$50M	1	—	—	Detail
Nov 8, 2021	Post-IPO Debt	$400M	—	—	—	Detail
Apr 9, 2021	Post-IPO Equity	$300M	—	—	—	Detail
Jun 7, 2020	Post-IPO Equity	$200M	—	—	—	Detail
Apr 30, 2019	Post-IPO Equity	$34M	3	Foris Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

9

19

Amyris is funded by 19 investors. National Institutes of Health and DSM are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Institutes of Health	Yes	Grant
DSM	Yes	Post-IPO Equity
Vivo Capital	Yes	Post-IPO Equity
Temasek Holdings	Yes	Post-IPO Equity
Total	Yes	Post-IPO Equity
Foris Ventures	—	Post-IPO Equity
John Doerr	—	Post-IPO Equity
Wei-Wu He	—	Post-IPO Equity
TotalEnergies Ventures	—	Post-IPO Equity
Biolding Investment	—	Post-IPO Equity

Employee Profiles

Number of Employee Profiles

25

Amyris has 25 current employee profiles, including Executive Kathleen Valiasek

Executive

Board member

Executive

Executive

Executive

Acquisition

Amyris has acquired 5 organizations. Their most recent acquisition was Draths Corporation on Nov 4, 2011. They acquired Draths Corporation for 0.

Date Company Name	Industry	Acquisition Type	Price
Nov 4, 2011 Draths Corporation	Chemical	—	—	Detail
Apr 14, 2021 Beauty Labs	Artificial Intelligence	acquisition	—	Detail
Jun 15, 2021 OLIKA	Health Care	management_buyout	—	Detail
Aug 24, 2021 MG Empower	Advertising	acquisition	—	Detail
Jan 24, 2022 MenoLabs	Wellness	acquisition	—	Detail